Jove
Visualize
Contact Us

Related Experiment Videos

Postdissolution gallstone recurrence. A clinical perspective.

J L Thistle1

  • 1Division of Gastroenterology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Digestive Diseases and Sciences
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.

The American journal of gastroenterology·2000
Same author

Elevated liver enzymes preceding vessel involvement in Takayasu's arteritis.

Journal of hepatology·1999
Same author

Pathophysiology of bile duct stones.

World journal of surgery·1998
Same author

Direct contact dissolution therapy.

Bailliere's clinical gastroenterology·1992
Same author

Current options for uncomplicated gallstones.

Contemporary internal medicine·1992
Same author

Safety of same-day sequential extracorporeal shock wave lithotripsy and dissolution of gallstones by methyl tert-butyl ether in dogs.

Mayo Clinic proceedings·1990
Same journal

Standardizing Transition of Care for Adolescents with Inflammatory Bowel Disease: The Need for a Unified Approach.

Digestive diseases and sciences·2026
Same journal

Rapid Gastric Emptying: Insights from a Large Cohort Study on a Controversial Disorder.

Digestive diseases and sciences·2026
Same journal

Readability, Quality, Understandability, and Actionability of ChatGPT Generated GI Patient Education Versus AGA Patient Center.

Digestive diseases and sciences·2026
Same journal

Distinctive Endoscopic Ultrasound Features of Pancreatic Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.

Digestive diseases and sciences·2026
Same journal

FIGThe Efficacy and Safety of Clip-Assisted Endoscopic Cyanoacrylate Injection for Gastric Varices: A Systematic Review and Meta-Analysis.

Digestive diseases and sciences·2026
Same journal

Gastroscopic Removal of a Duodenal Foreign Body in a 94-Year-Old Patient.

Digestive diseases and sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gallstones do not always recur after dissolution; over 50% of patients remain stone-free for years. Reversing underlying causes like cholesterol supersaturation is key to preventing gallstone recurrence.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Biliary tract disease

Background:

  • Gallstone recurrence after dissolution is a common concern.
  • The intuitive assumption of rapid recurrence in all patients is inaccurate.

Purpose of the Study:

  • To evaluate the actual rate and timeline of gallstone recurrence after dissolution.
  • To explore the complex pathogenic mechanisms underlying gallstone formation and recurrence.
  • To identify effective strategies for preventing gallstone recurrence.

Main Methods:

  • Analysis of patient data on gallstone recurrence post-dissolution.
  • Review of pathogenic factors including cholesterol supersaturation, nucleation/anti-nucleation factors, and gallbladder motility.
  • Assessment of therapeutic interventions targeting these mechanisms.

Related Experiment Videos

Main Results:

  • At least 50% of patients remain free of gallstones three to five years after complete dissolution.
  • Recurrence risk may decrease after the initial two to three years.
  • Pathogenic mechanisms are multifactorial and may resolve spontaneously.

Conclusions:

  • Gallstone recurrence is not inevitable, with a significant proportion of patients remaining recurrence-free.
  • Reversing pathogenic mechanisms, such as cholesterol desaturation with ursodiol, is the primary strategy for prevention.
  • Further research into novel bile acids, dietary interventions, and gallbladder motility enhancement is warranted.